De-Escalation of Antiplatelet Therapy to Evaluate Platelet Reactivity and Clinical Outcomes after Coronary Stenting in Patients at High Bleeding Risk and Recent Acute Coronary Syndrome: DESC-HBR trial De-Escalation di Terapia Antiaggregante per la valutazione della Reattività Piastrinica ed Outcome Clinici dopo Stenting Coronarico in Pazienti ad elevato Rischio Emorragico con recente Sindrome Coronarica Acuta: Trial DESC-HBR
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms DESC-HBR
Most Recent Events
- 06 Sep 2023 New trial record